Enzyme activities of hepatic glucose utilization in the fed and fasting genetically obese mouse at 4-5 months of age
- PMID: 6241916
- DOI: 10.1055/s-2007-1014893
Enzyme activities of hepatic glucose utilization in the fed and fasting genetically obese mouse at 4-5 months of age
Abstract
Activities of key enzymes in hepatic glucose utilization were compared between obese (C57BL/6J ob/ob) mice, their lean controls and outbred Swiss albino mice in the fed condition and during fasting. As liver hyperplasia and hepatocyte hypertrophy were present in the ob/ob mice at 4-5 months of age and changes in hepatic cellularity did occur with fasting, enzyme activity was expressed on the basis of protein, DNA, and wet weight. In the fed state, activities of glucokinase + hexokinase (glucose phosphorylating capability), phosphofructokinase and pyruvate kinase were significantly greater in livers of ob/ob mice when compared to those of the lean control. Glucokinase + hexokinase activities in livers of ob/ob mice remained significantly higher throughout the 48 h fast yet the activities of hepatic phosphofructokinase and pyruvate kinase, when expressed per g wet wt or mg protein, decreased so that a statistical difference from the fasted lean control was no longer detected. When expressed per 100 g body weight, hepatic glucokinase + hexokinase as well as phosphofructokinase and pyruvate kinase activities in obese mice were higher both in the fed and fasted states when compared to lean controls in the comparable nutritional condition. This increased capacity of key enzyme activities in hepatic glucose utilization can be attributed to liver hyperplasia found in ob/ob mice in both the fed and fasted condition. While higher hepatic glucose phosphorylating capability was maintained during fasting, the elevated specific activities of hepatic phosphofructokinase and pyruvate kinase in the obese mouse in the fed state decreased with starvation to values found in the lean control.
Similar articles
-
A metabolic profile of fed and fasting genetically obese mice at 4-5 months of age.Horm Metab Res. 1984 Dec;16 Suppl 1:37-42. doi: 10.1055/s-2007-1014894. Horm Metab Res. 1984. PMID: 6532936
-
Gluconeogenesis in perfused livers of genetically obese-hyperglycemic (ob/ob) mice.Horm Metab Res. 1979 Jan;11(1):9-14. doi: 10.1055/s-0028-1092672. Horm Metab Res. 1979. PMID: 428917
-
Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus.Diabetes Res. 1989 Feb;10(2):85-92. Diabetes Res. 1989. PMID: 2501061
-
Synchronous behavior pattern of key glycolytic enzymes: glucokinase, phosphofructokinase, and pyruvate kinase.Adv Enzyme Regul. 1966;4:59-81. doi: 10.1016/0065-2571(66)90007-0. Adv Enzyme Regul. 1966. PMID: 4295201 Review. No abstract available.
-
Sweet changes: glucose homeostasis can be altered by manipulating genes controlling hepatic glucose metabolism.Mol Endocrinol. 2004 May;18(5):1051-63. doi: 10.1210/me.2003-0357. Epub 2003 Dec 23. Mol Endocrinol. 2004. PMID: 14694084 Review.
Cited by
-
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.J Clin Invest. 2008 Mar;118(3):829-38. doi: 10.1172/JCI34275. J Clin Invest. 2008. PMID: 18317565 Free PMC article. Review.
-
Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice.Diabetologia. 2004 Nov;47(11):2022-31. doi: 10.1007/s00125-004-1571-8. Epub 2004 Dec 1. Diabetologia. 2004. PMID: 15599701
-
LRH-1-dependent glucose sensing determines intermediary metabolism in liver.J Clin Invest. 2012 Aug;122(8):2817-26. doi: 10.1172/JCI62368. Epub 2012 Jul 9. J Clin Invest. 2012. PMID: 22772466 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous